PECAM1 and myocardial infarction: A recent meta-analysis, including 599 participants (137 healthy subjects, 148 patients with SA, 147 patients with UA, and 167 patients with MI), found that the level of MVs, especially CD31+CD42− and CD144+ eEVs, was higher in patients with CHD than in healthy subjects and had an increasing trend with the degree of CHD: SA < UA < MI [56].